Outcomes of lung transplantation in adults with bronchiectasis

• Published in: BMC pulmonary medicine Vol. 18; no. 1; p. 82
• Main Authors: Birch, Jodie, Sunny, Syba S, Hester, Katy L M, Parry, Gareth, Kate Gould, F, Dark, John H, Clark, Stephen C, Meachery, Gerard, Lordan, James, Fisher, Andrew J, Corris, Paul A, De Soyza, Anthony
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 22-05-2018; BioMed Central; BMC
• Subjects: Adult; Adults; Analysis; Antibiotics; Bacterial infections; Biopsy; Bronchiectasis; Bronchiectasis - microbiology; Bronchiectasis - mortality; Bronchiectasis - surgery; Care and treatment; Cystic fibrosis; Databases, Factual; Disease; Female; Forced Expiratory Volume; Heart; Humans; Infections; Lung - physiopathology; Lung Transplantation; Male; Medical prognosis; Microbiology; Middle Aged; Morbidity; Mortality; Osteoporosis; Patient outcomes; Patients; Postoperative Complications - epidemiology; Pseudomonas; Pseudomonas aeruginosa; Pseudomonas infections; Pseudomonas Infections - epidemiology; Pulmonology; Quality of life; Respiratory function; Retrospective Studies; Sepsis; Surveillance; Survival; Survival Analysis; Time Factors; Transplantation; Transplants & implants; Treatment outcome; Young Adult; United Kingdom > UK; United States > US; Pseudomonas; Bronchiectasis; Transplantation
• ISSN: 1471-2466; 1471-2466
• DOI: 10.1186/s12890-018-0634-4

Lung transplantation is a well-established treatment for end-stage non-cystic fibrosis bronchiectasis (BR), though information regarding outcomes of transplantation remains limited. Our results of lung transplantation for Br are reported here.
A retrospective review of case notes and transplantation databases was conducted for patients that had underwent lung transplantation for bronchiectasis at the Freeman Hospital between 1990 and 2013.
Fourty two BR patients underwent lung transplantation, the majority (39) having bilateral sequential lung transplantation. Mean age at transplantation was 47.1 years. Pre-transplantation osteoporosis was a significant non-pulmonary morbidity (48%). Polymicrobial infection was common, with Pseudomonas aeruginosa infection frequently but not universally observed (67%). Forced expiratory volume in 1 second (% predicted) improved from a pre-transplantation mean of 0.71 L (22% predicted) to 2.56 L (79 % predicted) at 1-year post-transplantation. Our survival results were 74% at 1 year, 64% at 3 years, 61% at 5 years and 48% at 10 years. Sepsis was a common cause of early post-transplantation deaths.
Lung transplantation for end-stage BR is a useful therapeutic option, with good survival and lung function outcomes. Survival values were similar to other bilateral lung transplants at our centre. Pre-transplantation Pseudomonas infection is common.